# Franklin Biotechnology Discovery Fund

Franklin Biotechnology Discovery Fund is a registered fund series of Franklin Strategic Series (series S000006882). Net assets $1.0B as of 2026-04-30.

## Profile

- Series ID: S000006882
- Registrant: Franklin Strategic Series
- LEI: 6N5133EDK315FXQQM036
- Net assets: $1.0B
- Total assets: $1.1B
- As of: 2026-04-30

## Advisers

- [Franklin Advisers, Inc. (Advisor)](https://search.stillhousedata.com/firm/104517)

## Top holdings (113 reported)

_Showing 15 of 113 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| Jazz Pharmaceuticals plc | — | $57.5M | 554.73% |
| [Amgen, Inc.](https://search.stillhousedata.com/security/031162100) | — | $49.2M | 474.51% |
| [Gilead Sciences, Inc.](https://search.stillhousedata.com/security/375558103) | — | $48.3M | 466.03% |
| [Regeneron Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/75886F107) | — | $43.1M | 416.45% |
| [Vertex Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/92532F100) | — | $41.6M | 401.96% |
| [Argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $38.3M | 369.45% |
| [Franklin Institutional U.S. Government Money Market Fund](https://search.stillhousedata.com/security/457756500) | — | $31.6M | 305.28% |
| [Franklin Institutional U.S. Government Money Market Fund](https://search.stillhousedata.com/security/457756500) | — | $30.7M | 296.44% |
| Ascendis Pharma A/S | — | $29.8M | 287.26% |
| [Insmed, Inc.](https://search.stillhousedata.com/security/457669307) | — | $29.2M | 282.02% |
| [Revolution Medicines, Inc.](https://search.stillhousedata.com/security/76155X100) | — | $29.2M | 281.61% |
| [Praxis Precision Medicines, Inc.](https://search.stillhousedata.com/security/74006W207) | — | $26.0M | 250.59% |
| [Dianthus Therapeutics, Inc.](https://search.stillhousedata.com/security/252828108) | — | $23.8M | 229.50% |
| [Guardant Health, Inc.](https://search.stillhousedata.com/security/40131M109) | — | $21.7M | 209.28% |
| [Mirum Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/604749101) | — | $20.9M | 202.13% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $1.0B |
| 2026-01-31 | $1.0B |
| 2025-10-31 | $954.1M |
| 2025-07-31 | $726.9M |
| 2025-04-30 | $707.7M |
| 2025-01-31 | $803.2M |
| 2024-10-31 | $896.7M |
| 2024-07-31 | $941.1M |

## More

- [Registrant: Franklin Strategic Series](https://search.stillhousedata.com/registrant/872625)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000006882.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.